Fisher Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,062
| Closed | -$106K | – | 974 |
|
|
2021
Q1 | $106K | Sell |
15,062
-32,237
| -68% | -$227K | ﹤0.01% | 880 |
|
|
2020
Q4 | $227K | Buy |
47,299
+410
| +0.9% | +$1.97K | ﹤0.01% | 849 |
|
|
2020
Q3 | $273K | Buy |
46,889
+11
| +0% | +$64 | ﹤0.01% | 758 |
|
|
2020
Q2 | $316K | Buy |
46,878
+67
| +0.1% | +$452 | ﹤0.01% | 718 |
|
|
2020
Q1 | $298K | Sell |
46,811
-34,278
| -42% | -$218K | ﹤0.01% | 684 |
|
|
2019
Q4 | $845K | Sell |
81,089
-39,187
| -33% | -$408K | ﹤0.01% | 604 |
|
|
2019
Q3 | $473K | Hold |
120,276
| – | – | ﹤0.01% | 696 |
|
|
2019
Q2 | $1.79M | Buy |
120,276
+60,725
| +102% | +$903K | ﹤0.01% | 554 |
|
|
2019
Q1 | $1.48M | Buy |
59,551
+120
| +0.2% | +$2.98K | ﹤0.01% | 554 |
|
|
2018
Q4 | $1.07M | Hold |
59,431
| – | – | ﹤0.01% | 589 |
|
|
2018
Q3 | $1.75M | Buy |
59,431
+1,125
| +2% | +$33K | ﹤0.01% | 533 |
|
|
2018
Q2 | $2.65M | Buy |
58,306
+10,345
| +22% | +$470K | ﹤0.01% | 506 |
|
|
2018
Q1 | $2.53M | Hold |
47,961
| – | – | ﹤0.01% | 505 |
|
|
2017
Q4 | $3.26M | Buy |
47,961
+21,328
| +80% | +$1.45M | ﹤0.01% | 478 |
|
|
2017
Q3 | $2.2M | Buy |
+26,633
| New | +$2.2M | ﹤0.01% | 490 |
|